This morning there are a number of companies that would be on the radars of investors in a big way, and one of those could be CYIOS Corp. (OTC:CYIO). On Thursday, the company had been in significant focus in the news cycle after it made an announcement about Noir Medical Supplies, its fully owned subsidiary unit.
Noir Performance
The company announced yesterday that Noir Medical had delivered revenues of $5 million in the fourth fiscal quarter of 2024, and that proved to be a record-breaking number. The performance in the fourth quarter took the revenues earned by Noir Medical for the full year to as much as $14.4 million. The reflected a rise of $4.55 million from the previous fiscal year and worked out to an increase of as much as 20%.
Further Information
It was also noted in the news release that 2024 had been a watershed year for Noir Medical and had helped in transforming the company for the better. CYIOS Corp also stated that the acquisition of Noir Medical had been completed back on August 10, 2024, and since then it had proven to be a major success.
Management Comment
“2024 was a transformative year for CYIOS,” stated Chairman John O’Shea. “The extraordinary success of our Noir acquisition, which closed on August 10th, has not only strengthened our financial position but also set the foundation for a successful 2025.”
Traders Notes
| +/- EMA(20) | 0.0087 (+10.34%) |
| +/- SMA(50) | 0.0091 (+5.49%) |
| +/- SMA(200) | 0.0116 (-17.24%) |
| 5-Day Perf. | +6.67% |
| 1-Month Perf. | +23.08% |
| 3-Month Perf. | -21.31% |
| 6-Month Perf. | -18.64% |
| YTD Perf. | +18.52% |
| 1-Year Perf. | +23.08% |
| RSI(14) | 54.71 |
| ATR(14) | – |
| ADX(14) | 13.82 |
| Beta (5Y) | 0.15 |
